Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Health technology assessment in health-care decisions in the United States.

× No keyword cloud information.

14 in total

1. US FDA Modernization Act, section 114: uses, opportunities and implications for comparative effectiveness research.

Authors: Peter J Neumann; Pei-Jung Lin; Tom E Hughes
Journal: Pharmacoeconomics Date: 2011-08 Impact factor: 4.981

2. Health technology assessment and private payers' coverage of personalized medicine.

Authors: Julia R Trosman; Stephanie L Van Bebber; Kathryn A Phillips
Journal: J Oncol Pract Date: 2011-05 Impact factor: 3.840

3. Paying for personalized care: cancer biomarkers and comparative effectiveness.

Authors: Rahber Thariani; David L Veenstra; Josh J Carlson; Louis P Garrison; Scott Ramsey
Journal: Mol Oncol Date: 2012-03-06 Impact factor: 6.603

Review 4. A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy.

Authors: Joseph Menzin; Lisa M Lines; Daniel E Weiner; Peter J Neumann; Christine Nichols; Lauren Rodriguez; Irene Agodoa; Tracy Mayne
Journal: Pharmacoeconomics Date: 2011-10 Impact factor: 4.981

5. Health Technology Assessment Centers-an Infrastructure for Health Systems to Translate Evidence into Practice.

Authors: Ravi N Sharaf; Dhruv Khullar; Craig A Umscheid
Journal: J Gen Intern Med Date: 2020-01-03 Impact factor: 5.128

6. Developing a model of a patient-group pathway to accessing cancer clinical trials in Canada.

Authors: G Batist; S Michaud; D P Richards; F Servidio-Italiano; B D Stein
Journal: Curr Oncol Date: 2018-12-01 Impact factor: 3.677

Review 7. Integration of new technology into clinical practice after FDA approval.

Authors: Ashul Govil; Steven C Hao
Journal: J Interv Card Electrophysiol Date: 2016-08-27 Impact factor: 1.900

8. Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.

Authors: Kristen Underhill
Journal: Am J Law Med Date: 2012

9. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.

Authors: Roland Buhl; Christian Gessner; Wolfgang Schuermann; Karin Foerster; Christian Sieder; Simone Hiltl; Stephanie Korn
Journal: Thorax Date: 2015-02-12 Impact factor: 9.139

10. International comparison of the factors influencing reimbursement of targeted anti-cancer drugs.

Authors: Carol Sunghye Lim; Yun-Gyoo Lee; Youngil Koh; Dae Seog Heo
Journal: BMC Health Serv Res Date: 2014-11-29 Impact factor: 2.655